Statera Biopharma Inc (STAB)

OTC Markets
Currency in USD
0.001
0.000(0.00%)
Delayed Data
STAB Scorecard
Full Analysis
Stock generally trades with high price volatility
Trading near 52-week High
Fair Value
Day's Range
0.0010.001
52 wk Range
0.0010.001
Key Statistics
Edit
Prev. Close
-
Open
0.001
Day's Range
0.001-0.001
52 wk Range
0.001-0.001
Volume
-
Average Vol. (3m)
19.65K
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
STAB Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins
Show more

Statera Biopharma Inc Company Profile

Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body’s immune system and restore homeostasis. The company is developing therapies designed to directly elicit within patients a response of antigen-specific killer T-cells and antibodies, thereby activating essential immune defenses against autoimmune, inflammatory, infectious diseases, and cancers. It has clinical programs for Crohn’s disease (STAT-201), hematology (Entolimod), pancreatic cancer (STAT-401), and COVID-19 (STAT-205), as well as fibromyalgia and multiple sclerosis. The company was formerly known as Cytocom, Inc. and changed its name to Statera Biopharma, Inc. in September 2021. Statera Biopharma, Inc. is based in Fort Collins, Colorado. Statera Biopharma, Inc. is a subsidiary of Biostax Corp.

Compare STAB to Peers and Sector

Metrics to compare
STAB
Peers
Sector
Relationship
P/E Ratio
0.0x−3.8x−0.5x
PEG Ratio
0.000.020.00
Price / Book
0.0x2.3x2.6x
Price / LTM Sales
0.0x22.9x3.0x
Upside (Analyst Target)
0.0%177.2%54.7%
Fair Value Upside
Unlock0.2%9.3%Unlock

Earnings

Latest Release
Nov 18, 2024
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Statera Biopharma (STAB) Stock Price Today?

The Statera Biopharma stock price today is 0.001

What Stock Exchange Does Statera Biopharma Trade On?

Statera Biopharma is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Statera Biopharma?

The stock symbol for Statera Biopharma is "STAB."

What Is the Statera Biopharma Market Cap?

As of today, Statera Biopharma market cap is 72.58K.

What is Statera Biopharma Earnings Per Share?

The Statera Biopharma EPS is -1.91.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.